Recombinant SARS-CoV-2 (2019-nCoV) Spike RBD protein

Cat No.
ATGP3968

Size

QTY

List




Product Information

Product Type
Recombinant Protein
Expression System
HEK293
Domain
319-541aa
UniProt No.
P0DTC2
NCBI Accession No.
QHD43416.1
Alternative names
Severe acute respiratory syndrome coronavirus 2, COVID-19, COVID-19 virus, COVID19, HCoV-19, Human coronavirus 2019, SARS-2, SARS-CoV2, SARS2, Wuhan coronavirus, SARS-CoV-2 SP RBD, 2019-nCoV SP RBD, 2019-nCoV, 2019-nCoV; Spike RBD Protein

Product Specification

Molecular Weight
26.3kDa (233aa)
Concentration
0.5mg/ml (determined by Absorbance at 280nm)
Formulation
Liquid. In Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 95% by SDS - PAGE
Bioactivity
Measured by its binding ability in a functional ELISA with Human ACE-2 (CAT# ATGP3963)
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain

Biological Activity

SARS-CoV-2 Spike RBD is coated at 5ug/ml (100 ul/well) can bind ACE-2 (CAT# ATGP3963) in a Functional ELISA assay.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.